Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
This study has been completed.
Study NCT00004268   Information provided by National Center for Research Resources (NCRR)
First Received: October 18, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Orthostatic Hypotension
Additional conditions recognized in this trial
Hypotension
Hypotension, Orthostatic
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
midodrine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Autonomic Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
National Center for Research Resources (NCRR)
Roberts Pharmaceutical


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services